3. In section 128A (EU compulsory licences)—
[F1(a)in the heading for “EU compulsory”, substitute “Compulsory pharmaceutical”;
(b)in subsection (1), for “an “EU compulsory”, substitute “a “compulsory pharmaceutical”;]
(c)in subsection (2)—
(i)for “EU compulsory”, substitute “ compulsory pharmaceutical ”;
(ii)“an EU compulsory”, substitute “a compulsory pharmaceutical”;
(d)in subsection (5), for “an EU compulsory”, substitute “ a compulsory pharmaceutical ”.
Textual Amendments
F1Reg. 3(a)(b) substituted (31.12.2020 immediately before IP completion day) by The Intellectual Property (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1050), regs. 1(2), 27
Commencement Information
I1Reg. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1